Objective: Comparison of effectiveness between the pylorus-preserving pancreaticoduodenectomy ("pylorus-preserving Whipple" ͓PPW͔) and the classic Whipple (CW) procedure. Methods: A systematic literature search (Medline, Embase, Cochrane Library, Biosis, Science Citation Index, Ovid Journals) was performed to identify all eligible articles. Randomized controlled trials (RCTs) comparing PPW versus CW for periampullary and pancreatic carcinoma were eligible for inclusion. The methodologic quality of included studies was evaluated independently by 2 authors. Quantitative data on perioperative parameters (blood loss, transfusion, operation time, and length of hospital stay), mortality, morbidity, and survival were extracted from included studies for meta-analysis. Pooled estimates of overall treatment effect were calculated using a random effects model. Results: In total, 1235 abstracts were retrieved and checked for eligibility and 6 RCTs finally included. The critical appraisal revealed vast heterogeneity with respect to methodologic quality and outcome parameters. The comparison of overall in-hospital mortality (odds ratio, 0.49; 95% CI, 0.17 to 1.40; P ϭ 0.18), morbidity (odds ratio 0.89; 95% CI, 0.48 to 1.62; P ϭ 0.69), and survival (hazard ratio, 0.74; 95% CI, 0.52 to 1.07; P ϭ 0.11) showed no significant difference. However, operating time (weighted mean difference, Ϫ68.26 minutes; 95% CI, Ϫ105.70 to Ϫ30.83; P ϭ 0.0004), and intraoperative blood loss (weighted mean difference, Ϫ766 mL; 95% CI, Ϫ965.26 to Ϫ566.74; P ϭ 0.00001) were significantly reduced in the PPW group. Conclusion: Hence, in the absence of relevant differences in mortality, morbidity, and survival, the PPW seems to be as effective as the CW. Given obvious clinical and methodological interstudy heterogeneity, efforts should be intensified in the future to perform high quality RCTs of complex surgical interventions on the basis of well defined outcome parameters. FIGURE 2. Meta-analysis of parameters of mortality and morbidity. Effect estimates (odds ratio; 95% CI). Pooled treatment effect is shown as a diamond that spans the 95% CI. Study quality assessment: allocation concealment adequate (A), unclear (B), inadequate (C), or not used (D).
P ancreatic cancer is the fourth leading cause of cancer death in men and the fifth in women, accounting for 4.8% and 5.5% of cancer deaths in men and women, respectively. 1, 2 As shown in large case series, 3 the aggressive biology of these tumors and the high local recurrence rate in combination with the early metastatic spread lead to 5-year survival rates between 11% and 21% after resection. 4 Surgical resection by means of pancreaticoduodenectomy provides the only chance of cure for patients with periampullary and pancreatic carcinoma. 4 -6 Advances in surgical technique have reduced the operative mortality rate to below 5% in high-volume centers. 6 -8 Nevertheless, operative morbidity remains high, occasionally approaching 30% to 40%, 9 -11 most often including pancreatic fistula, intra-abdominal abscesses, sepsis, and delayed gastric emptying (DGE).
Two operation techniques are performed predominantly in the treatment of periampullary and pancreatic head cancer: the classic Whipple operation (CW) developed by Kausch 12 and Whipple 13 and the pylorus-preserving Whipple procedure (PPW) inaugurated by Watson 14 and popularized by Traverso and Longmire. 15 The CW operation consists of an en bloc removal of the pancreatic head, the duodenum, the common bile duct, the gall bladder, and the distal portion of the stomach together with the adjacent lymph-nodes. 16 This operation can lead to specific complications such as early and late dumping, postoperative weight loss, 17 and postoperative reflux. 18 Leaving the functioning pylorus at the gastric outlet, the PPW represents a surgical alternative that is being performed by an increasing number of surgeons.
Which is the better technique? This question is still being debated. Some authors suggested possible advantages of the PPW procedure in terms of reduced operation time, 19 less blood loss, better access to the biliary anastomosis for postoperative endoscopy in patients with recurrent biliary obstruction, improved postoperative weight gain, 17 and higher quality of life. 20 On the other hand, the reported incidence of early DGE seemed to be higher in the PPW group in previous series. [21] [22] [23] Moreover, it has not been unequivocally shown that the lesser trauma induced by a PPW, beneficial as it may be to the patient, is yet oncologically adequate.
The inconclusive results of several nonrandomized studies have triggered a number of randomized controlled trials (RCTs). A qualitative appraisal and statistical aggregation of the individual RCTs that will give a more precise estimate of the treatment effect is still lacking, as systematic reviews of high quality primary studies represent, if rigorously performed, the highest level of evidence. 24 The primary objective of this study is to analyze the existing evidence regarding the PPW and CW procedures in a systematic review (SR) and to provide a meta-analysis (MA) of perioperative parameters (blood loss, transfusion, operation time), postoperative mortality and morbidity, length of hospital stay, and survival.
METHODS
The rationale and design of this study were prepared according to the described methodology 25 
Search Strategy
The search strategy in Medline (PubMed) was based on the following search terms (Medical Subject Heading terms and text words) with the appropriate combinations:
(Pylorus preserv* OR whipple OR pancreat* resection OR pancreatojejunostom* OR pancreaticojejunostom* OR pancreaticojejunostomy ͓MeSH͔ pancreatoduodenectom* OR pancreaticoduodenectom* OR pancreaticoduodenectomy ͓MeSH͔ OR duodenopancreatectom* OR pancreatectom* OR pancreatectomy ͓MeSH͔) AND (Adenocarcinom* panc* OR panc* tumor* OR panc* carc* OR panc* cancer* OR panc* neoplas* OR Pancreatic Neoplasm ͓MeSH͔) AND (randomized controlled trial ͓pt͔ OR controlled clinical trial ͓pt͔ OR randomized controlled trials ͓mh͔ OR random allocation ͓mh͔ OR double-blind method ͓mh͔ OR singleblind method ͓mh͔ OR clinical trial ͓pt͔ OR clinical trials ͓mh͔ OR ("clinical trial" ͓tw͔) OR ((singl* ͓tw͔ OR doubl* ͓tw͔ OR trebl* ͓tw͔ OR tripl* ͓tw͔) AND (mask* ͓tw͔ OR blind* ͓tw͔)) OR placebos ͓mh͔ OR placebo* ͓tw͔ OR random* ͓tw͔ OR research design ͓mh:noexp͔ NOT (animal ͓mh͔ NOT human ͓mh͔)).
Study Selection
RCTs comparing CW versus PPW for periampullary and pancreatic carcinoma were eligible for this SR. Only RCTs reporting on the following outcomes were selected for data extraction: quantitative data on perioperative parameters (blood loss, transfusion, operation time, length of hospital stay), postoperative mortality and morbidity, and survival.
Two authors (M.K.D. and C.H.) independently identified and screened the search findings for potentially eligible RCTs. Abstracts and full articles were obtained for detailed evaluation and eligible trials were included into the SR. Any disagreements during the selection process were resolved by discussion with a third author (C.M.S.).
Data Extraction and Analysis
According to international recommendations, 26, 27 the methodologic quality of RCTs was assessed using a standardized form to extract prespecified parameters. 28 Thus, the critical appraisal of the extracted data included rating of the randomization procedure, allocation concealment, sample size, consistency of the study population, length and quality of follow-up, rate of patients lost to follow-up, and statistical analysis of individual trials.
Two authors (M.K.D. and C.H.) independently extracted quantitative data on perioperative parameters, postoperative mortality, morbidity, and survival ( Table 1 ). The synchronized extraction results were pooled as estimates of overall treatment effects in a MA and presented as weighted odds ratios (OR) for parameters of mortality and morbidity, weighted mean difference (WMD), a weighted average of the differences in means, for perioperative parameters and the corresponding 95% confidence intervals (CI). Data for the pooled overall survival were generated by extracting events 
RESULTS

Excluded Studies
The systematic literature search retrieved 1235 abstracts. During this process of study selection, 1211 screened abstracts had to be excluded. Of the remaining 24 screened full articles, 18 did not fulfill the inclusion criteria. Most of the excluded articles did not cover surgical aspects of the comparison of PPW and CW nor provide quantitative data on the prespecified outcome parameters ( Table 2 ; Fig. 1 ).
Included Studies
Six RCTs 20,32-36 involving 578 randomized patients were eligible. Because of a per-protocol analysis of 5 trials, 20, 32, 33, 35, 36 quantitative data of 465 analyzed patients comparing the PPW (229 patients) and the CW (236 patients) procedure were found suitable for the SR (Table 3) Besides obvious variation in the sample size (range from 36 32 to 240 33 ) the evaluation of the study population baseline data revealed adequate consistency: all analyzed patients were included because of resectable pancreatic or periampullary cancer. Moreover, 4 studies 20, 33, 34, 36 provided data on resection margin status following PPW or CW, respectively: all studies showed a balanced interstudy and intrastudy distribution of R0 resections (mean R0 resection, 91.1% ͓PPW͔; 90.4% ͓CW͔). In addition, we observed a similar distribution of positive lymph node status in 3 studies (mean positive lymph node status: 54.4% ͓PPW͔; 60.3% ͓CW͔). 20, 33, 34 The methodologic appraisal of the single studies revealed considerable heterogeneity in study design. Only 2 trials, the largest (170 34 and 240 33 patients, respectively) described the underlying sample size calculation, whereas 4 trials 20, 32, 35, 36 did not justify the number of included patients.
The randomization process was described in 3 trials, 33, 34, 36 the 3 others 20,32,35 did not specify the process of random allocation adequately. Only 2 trials 33,34 described how allocation concealment was maintained and blinded outcome assessment was performed.
The trials by Seiler et al 33 and Tran et al 34 provided the most comprehensive definitions. Four trials 20, 32, 35, 36 did not specify the criteria of their endpoints adequately.
Follow-up quality was evaluated by assessing the follow-up sequence and the length of follow-up. Median follow-up varied from 18 months 35 up to 144 months; 36 one study 32 did not report and specify on the follow-up at all.
Statistical analysis was performed in one trial 34 according to the intention-to-treat principle; 5 trials 20, 32, 33, 35, 36 applied a per-protocol analysis.
Regarding the perioperative management, we observed a nonstandardized administration of somatostatin as to dosage, route, frequency, and length. Two of the 6 RCTs reported the use of octreotide (100 -200 g). 33, 34 Most of the trials discarded the use of erythromycin 33, 34 or did not mention its perioperative application. 20, 32, 35, 36 
Meta-Analysis of Mortality, Morbidity, Perioperative Parameters, and Survival
Six studies 20, [32] [33] [34] [35] [36] provided quantitative data on overall mortality and morbidity in addition to rates of pancreatic fistula, wound infection, postoperative bleeding, DGE, and biliary leakage following the PPW and the CW procedures, respectively.
Mortality and Overall Morbidity
Both mortality and postoperative overall morbidity showed similar ranges in the PPW group (mortality, 0% 35 
Perioperative Parameters
MA of perioperative parameters such as blood loss, red blood cell transfusion, operating time, and length of hospital stay of 3 RCTs 20,32,35 demonstrated a significant reduction of operating time ͓min͔ for the PPW (WMD, Ϫ68.26; 95% CI, Ϫ105.70 to Ϫ30.83; P ϭ 0.0004; I 2 test, 67.5% data heterogeneity). Intraoperative blood loss (mL) could be extracted in an analyzable way from only one trial 32 and was significantly reduced in the PPW group (WMD, Ϫ766.00; 95% CI, Ϫ965.26 to Ϫ566.74; P Ͻ 0.00001). In contrast, the summarized effect estimate of blood replacement (units) indicated similar application of blood products intraoperatively (WMD, Ϫ0.65; 95% CI, Ϫ1.92 to 0.61; P ϭ 0.31; I 2 test, 0% data heterogeneity). Length of hospital stay (days) showed similar results in both groups (WMD, Ϫ1.80; 95% CI, Ϫ8.94 to 5.34; P ϭ 0.62), with only one article providing adequate data for pooling 20 (Fig. 3 ).
Parameters of Morbidity
Data on pancreas associated morbidity were inconclusive due to broad ranges of rates for DGE, occurrence of pancreatic fistula, and biliary leakage (Table 4 ). To further differentiate the underlying heterogeneity, MA of these parameters was performed.
Five studies [32] [33] [34] [35] [36] provided data on the occurrence of DGE. Given statistical heterogeneity (I 2 test 75.6%), 3 studies 32, 35, 36 were in favor of CW, one in favor of PPW, 33 whereas one study 34 The summarized effect size of 3 RCTs 32-34 comparing biliary leakage following PPW and CW showed no difference: 2 of 165 (1.2%) in the PPW group versus 1 of 168 (0.5%) in the CW group (OR, 1.35; 95% CI, 0.10 to 18.55; P ϭ 0.82; I 2 test, 28.3%). Three studies 32-34 evaluated postoperative bleeding, with 8 of 165 patients (4.8%) in the PPW group and eleven of 168 patients (6.5%) in the CW group, which was statistically nonsignificant (OR, 0.74; 95% CI, 0.29 to 1.88; P ϭ 0.53; I 2 test, 0%). Wound infection showed similar levels and occurred in 10 of 119 (8.4%) patients in the PPW group and in 13 of the 132 (9.8%) patients in the CW group (OR, 0.85; 95% CI, 0.35 to 2.05; P ϭ 0.72; I 2 test, 0%). (Fig. 2) .
Survival
Four studies [32] [33] [34] 36 provided survival data suitable for MA: long-term results (60 months 32, 34, 36 and 36 months, 33 actuarial Kaplan-Meier analysis) from a total of 284 patients (138 PPW; 146 CW) were evaluated comparing the hazard ratios (HR) and the corresponding 95% CI in the random effects model. As in the findings of the individual trials, the summarized effect size indicated no difference in survival following PPW or CW, respectively (HR, 0.74; 95% CI, 0.52 to 1.07; P ϭ 0.11; I 2 test, 31.1%) ( Fig. 3 ).
DISCUSSION
The preservation of the pylorus in patients undergoing duodenopancreatectomy for cancer has been a controversial issue for the last decade. Numerous studies have been performed, including several RCTs, but the cumulative knowledge gained from these studies needed to be captured in a quantitative summary of the results to establish whether the pylorus-preserving pancreaticoduodenectomy (PPW) is a better technique than the classic Whipple (CW).
From a curative perspective, this SR with MA provides further evidence that the CW is not better than the PPW procedure. Pooled long-term results of 4 RCTs showed no difference in terms of overall survival (HR, 0.74; P ϭ 0.11). Our findings are in line with a recently published study by Bassi et al 37 where survival data were correlated with the type of surgery by multivariate analysis. The results indicated that neither the type of surgery (PPW vs. CW: HR, 0.80; P ϭ 0.078) nor the occurrence of postoperative complications significantly affected the hazard of death, once tumor staging is taken into account (grade, nodal status, and maximum tumor size). As shown by Neoptolemos et al, 38 not the resection margin status R0/R1, but the tumor grade and lymph node status were by far the most powerful prognostic factors of survival.
Mortality and cumulative morbidity are not significantly different between both techniques so that they can be said to be in clinical equipoise. As for surgically and clinically relevant parameters of morbidity, we found in particular no significant differences for the occurrence of pancreatic fistula (OR, 0.84; P ϭ 0.63), biliary leakage (OR, 1.35; P ϭ 0.82), and postoperative bleeding (OR, 0.74; P ϭ 0.53).
Concerning DGE, previous reports of nonrandomized cohort studies 22, 39 stating higher rates of DGE in the PPW procedure could not be confirmed by the results of prior RCTs and our MA: Three studies 32, 35, 36 Our Cochrane highly sensitive search strategy was approved by an expert in the field (G.A.) but, because of incompleteness, may still be biased. In an attempt to identify all relevant studies, we contacted experts in pancreatic surgery and clinical research to identify ongoing trials. However, no additional study has been brought to our knowledge. Systematic reviews currently provide the best methodology to summarize the existing evidence, but the quality of such reviews depends on the quality of the primary studies. 40, 41 In our case, the reviewed studies are partially marred by bias and clinical heterogeneity, which may distort our results.
The fact that the randomization process has been carried out differently in the reviewed studies can be considered as a source of bias, as adequate randomization and allocation concealment generates balanced groups for known, unknown, and unmeasured confounders. Three studies 33, 34, 36 of the 6 included studies provided adequate description of the randomization process, whereas the 3 other studies 20, 32, 35 failed to describe the method of allocation satisfactorily.
Moreover, maintained allocation concealment and blinding of the outcome assessor were specified only in 2 trials. 33, 34 Also, median follow-up and follow-up sequences varied significantly between the individual studies (median follow-up, 18 35 months to 144 months 36 ). This insufficient reporting on inconsistent follow-up sequences is a possible indicator of performance bias.
Furthermore, we found varying or even lacking definitions of surrogate parameters such as pancreatic fistula and At the moment, there are no internationally accepted scaled definitions for surgical outcome parameters in pancreatic cancer surgery. Efforts, such as the consensus conference of the international study group for definition of postoperative pancreatic fistula, should be encouraged to reduce interobserver variability. 42 Concerning the use of antibiotics, somatostatin, drains, nasogastric tubes, etc, we observed a nonstandardized therapeutic concept or even nonreporting with respect to dosage, route, frequency, and length of administration. Thus, the considerable variation of perioperative management is a further indicator for of interstudy heterogeneity that may influence the external validity of the summarized results.
Another possible source of bias lies in the statistical analysis. Only one trial 34 used the intention-to-treat method, whereas the 5 remaining trials 20, 32, 33, 35, 36 applied the PP analysis. This distorted analysis of patients lost to follow-up or missing information on excluded patients (attrition bias) makes it difficult to decide whether the remaining study population is representative (external validity). Moreover, statistical analysis of obviously underpowered trials 32 reduces the explanatory power of these results.
In this context, we should point out that we did not investigate the influence of the neo-and adjuvant treatment, as relevant data were not reported in an interpretable way in the reviewed studies. Therefore, our results may be biased since adjuvant treatment, eg, chemotherapy or chemo-radiation, represents a possible confounder of an impact on survival, mortality and morbidity in a neoadjuvant setting.
The trial by Yeo et al 43, 44 had to be excluded from our analyses due to the fact that patients were randomized for pancreaticoduodenectomy with standard versus extended lymphadenectomy and not explicitly for PPW versus CW. Although 86% of patients of the "standard" group were subjected to a PPW and all of the radical (extended) group underwent a classic Whipple procedure with retroperitoneal lymphadenectomy, inclusion of these 294 patients might have contorted the results.
Despite the mentioned sources of clinical and methodologic heterogeneity, we still observed adequate balanced groups when we compared interstudy baseline population characteristics: all analyzed patients were included due to suspect pancreatic or periampullary carcinoma. Our SR also revealed a balanced distribution of R0/R1 resections (mean R0 resection, 91.1% ͓PPW͔; 90.4% ͓CW͔) and lymph node status (mean positive lymph node status, 54.4% ͓PPW͔; 60.3% ͓CW͔). The calculated average level of the statistical heterogeneity of all 12 meta-analytic approaches indicated moderate heterogeneity of 22.4% (I 2 test). Nevertheless, given obvious sources of clinical and methodologic heterogeneity, we decided to compute the statistics of our MA using the random effects model, which allows for variation in the treatment effects of the individual studies but also provides a more conservative pooled effect estimate. 30 Because of multifactorial heterogeneity and only 6 trials included, subgroup analysis seemed not to be feasible.
CONCLUSION
Given these obvious sources of bias (small sample size, lacking definition of outcome parameters, inexplicit random- ization, and allocation concealment), the results of our systematic review and meta-analysis should be interpreted with caution. We must recognize that neither PPW nor CW has been showed to be the better technique. To demonstrate a clear superiority of the PPW technique, much larger and rigorously designed studies would be needed than currently available. On the other hand, the present study illustrates an intolerable situation. Six trials of the highest level of evidence addressing the same surgical problem still show major clinically relevant heterogeneity. This highlights the urgent need for the surgical community to develop standardized RCTs for complex interventions. To reach an evidence-based consensus on refined definitions of surgical interventions and their possible outcome parameters, international cooperation is called upon. This systematic review and meta-analysis might serve as a basis for such a development.
